Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Nov;42(11):1723-1732.
doi: 10.1007/s00134-016-4447-8. Epub 2016 Sep 30.

Neurally adjusted ventilatory assist as an alternative to pressure support ventilation in adults: a French multicentre randomized trial

Affiliations
Randomized Controlled Trial

Neurally adjusted ventilatory assist as an alternative to pressure support ventilation in adults: a French multicentre randomized trial

A Demoule et al. Intensive Care Med. 2016 Nov.

Abstract

Purpose: Neurally adjusted ventilatory assist (NAVA) is a ventilatory mode that tailors the level of assistance delivered by the ventilator to the electromyographic activity of the diaphragm. The objective of this study was to compare NAVA and pressure support ventilation (PSV) in the early phase of weaning from mechanical ventilation.

Methods: A multicentre randomized controlled trial of 128 intubated adults recovering from acute respiratory failure was conducted in 11 intensive care units. Patients were randomly assigned to NAVA or PSV. The primary outcome was the probability of remaining in a partial ventilatory mode (either NAVA or PSV) throughout the first 48 h without any return to assist-control ventilation. Secondary outcomes included asynchrony index, ventilator-free days and mortality.

Results: In the NAVA and PSV groups respectively, the proportion of patients remaining in partial ventilatory mode throughout the first 48 h was 67.2 vs. 63.3 % (P = 0.66), the asynchrony index was 14.7 vs. 26.7 % (P < 0.001), the ventilator-free days at day 7 were 1.0 day [1.0-4.0] vs. 0.0 days [0.0-1.0] (P < 0.01), the ventilator-free days at day 28 were 21 days [4-25] vs. 17 days [0-23] (P = 0.12), the day-28 mortality rate was 15.0 vs. 22.7 % (P = 0.21) and the rate of use of post-extubation noninvasive mechanical ventilation was 43.5 vs. 66.6 % (P < 0.01).

Conclusions: NAVA is safe and feasible over a prolonged period of time but does not increase the probability of remaining in a partial ventilatory mode. However, NAVA decreases patient-ventilator asynchrony and is associated with less frequent application of post-extubation noninvasive mechanical ventilation.

Trial registration: clinicaltrials.gov Identifier: NCT02018666.

Keywords: Mechanical ventilation; Neurally adjusted ventilatory assist; Noninvasive ventilation; Patient–ventilator asynchrony; Ventilator-free days; Weaning.

PubMed Disclaimer

Comment in

References

    1. Crit Care. 2015 Feb 25;19:56 - PubMed
    1. Intensive Care Med. 2013 Aug;39(8):1368-76 - PubMed
    1. Crit Care Med. 2010 Feb;38(2):518-26 - PubMed
    1. Nat Med. 1999 Dec;5(12):1433-6 - PubMed
    1. Intensive Care Med. 2006 Oct;32(10):1515-22 - PubMed

Publication types

MeSH terms

Associated data

LinkOut - more resources